Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Cost/benefit aspects on thromboprophylaxis

Bergqvist, David and Mätzsch, Thomas LU (1993) In Haemostasis 23(Suppl. 1). p.15-19
Abstract
Several studies have shown thromboprophylaxis of any kind to be more cost-effective than no prophylaxis or general diagnostic surveillance and selective treatment. Little has been written on low molecular weight heparins from the cost-effectiveness point of view. This preliminary study shows low molecular weight heparin to be more cost-effective than standard low-dose heparin in most situations of prophylaxis.
Please use this url to cite or link to this publication:
author
and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Haemostasis
volume
23
issue
Suppl. 1
pages
15 - 19
publisher
Karger
external identifiers
  • pmid:8388349
  • scopus:0027502386
ISSN
0301-0147
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)
id
02d25bff-d679-4cf5-9ee8-087aee46069e (old id 1107304)
date added to LUP
2016-04-01 16:05:21
date last changed
2025-10-14 10:37:04
@article{02d25bff-d679-4cf5-9ee8-087aee46069e,
  abstract     = {{Several studies have shown thromboprophylaxis of any kind to be more cost-effective than no prophylaxis or general diagnostic surveillance and selective treatment. Little has been written on low molecular weight heparins from the cost-effectiveness point of view. This preliminary study shows low molecular weight heparin to be more cost-effective than standard low-dose heparin in most situations of prophylaxis.}},
  author       = {{Bergqvist, David and Mätzsch, Thomas}},
  issn         = {{0301-0147}},
  language     = {{eng}},
  number       = {{Suppl. 1}},
  pages        = {{15--19}},
  publisher    = {{Karger}},
  series       = {{Haemostasis}},
  title        = {{Cost/benefit aspects on thromboprophylaxis}},
  volume       = {{23}},
  year         = {{1993}},
}